Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Tags:
Eli Lilly, ADA, diabetes, heart attack, stroke, Trulicity, Novo Nordisk, semaglutide
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Wed, 06/5/19 - 12:01 am
Tags:
Novo Nordisk, type 2 diabetes, diabetes, chronic kidney disease
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Motley Fool
Thu, 05/9/19 - 11:20 pm
Tags:
Novo Nordisk, earnings, diabetes, oral semaglutide, FDA
Renewable Energy Will Power all of Novo Nordisk’s Production Facilities by 2020
BioSpace
Wed, 05/1/19 - 12:10 pm
Tags:
Novo Nordisk, drug manufacturing, renewable energy, environmental concerns
Novo seeks Victoza label expansion with fresh pediatric trial results
Biopharma Dive
Mon, 04/29/19 - 09:33 pm
Tags:
Novo Nordisk, type 2 diabetes, pediatrics, Victoza
Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs
TheStreet.com
Fri, 04/12/19 - 10:05 am
Tags:
NASH, Gilead Sciences, Novo Nordisk, clinical trials
Novo Nordisk seeks FDA nod for oral diabetes pill
Drug Delivery Business News
Thu, 03/21/19 - 09:49 am
Tags:
Novo Nordisk, FDA, semaglutide, diabetes
Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
Pharmaceutical Business Review
Wed, 03/20/19 - 12:16 pm
Tags:
Novo Nordisk, Teva Pharmaceutical, patents, Victoza, diabetes
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Mon, 03/18/19 - 05:05 pm
Tags:
Novo Nordisk, diabetes, Teva Pharmaceutical, Victoza, semaglutide
Novo Nordisk Launches Innovation Platform in China
CP Wire
Fri, 03/8/19 - 09:54 am
Tags:
Novo Nordisk, China, innovation, Innovo
Fri, 03/8/19 - 09:46 am
Tags:
Novo Nordisk, China
In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data
Endpoints
Mon, 03/4/19 - 10:20 am
Tags:
Novo Nordisk, Trulicity, Ozempic, Eli Lilly, diabetes
Abbott, Novo Nordisk ink deal for digital diabetes tools
Drug Delivery Business News
Wed, 02/20/19 - 06:13 pm
Tags:
Abbott Labs, Novo Nordisk, digital health, digital pharma, insulin, diabetes, FreeStyle Libra, devices, connected insulin pen
IP trouble defers launch of Novo's long-acting hemophilia therapy
Endpoints
Wed, 02/20/19 - 10:03 am
Tags:
Novo Nordisk, Eseproct, hemophilia, Roche, Hemlibra
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
Wed, 02/13/19 - 10:06 am
Tags:
obesity, Sanofi, Novo Nordisk, AstraZeneca
An oral insulin delivery system inspired by tortoises
Fierce Biotech
Thu, 02/7/19 - 11:19 pm
Tags:
diabetes, insulin, drug delivery, MIT, Brigham and Women's, Novo Nordisk, OI388GT
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
Tags:
FDA, DWP-450, Evolus, MOTIF BIO PLC/S ADR, Iclaprim, Bausch Health, Duobrii, Merck, Keytruda, Incyte, Novartis, ruxolitinib, Novo Nordisk, N8-GP
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
Novo bets on swift FDA review for oral diabetes drug semaglutide
Endpoints
Fri, 02/1/19 - 09:50 am
Tags:
Novo Nordisk, earnings, semaglutide, FDA
On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe
Fierce Pharma
Thu, 01/31/19 - 11:53 pm
Tags:
Sanofi, Novo Nordisk, diabetes, insulin, drug pricing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.